Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-10 Purchase |
2021-06-10 4:57 pm |
Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director |
20,000 | $5.69 | $113,800 | 66,250 (Direct) |
View |
| 2020-08-26 Sale(A) |
2020-08-28 5:11 pm |
Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner |
148,700 | $8.108 | $1,205,660 | 5,819,383 (Direct) |
View |
| 2020-08-25 Sale |
2020-08-27 7:06 pm |
Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner |
164,488 | $8.0716 | $1,327,684 | 5,819,383 (Direct) |
View |
| 2020-06-30 Sale |
2020-06-30 5:54 pm |
Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director |
13,000 | $7.35 | $95,550 | 26,250 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-03 Option Award |
2022-01-05 7:08 pm |
2023-01-03 2032-01-03 |
Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2021-09-28 Tax Withholding |
2021-09-30 5:48 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
27,750 | $6.5 | 1,924,807 (Direct) |
View |
| 2021-09-28 Option Award |
2021-09-30 5:48 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
55,500 | $0 | 1,924,807 (Direct) |
View |
| 2021-09-28 Tax Withholding |
2021-09-30 5:45 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
2,839 | $6.5 | 177,535 (Direct) |
View |
| 2021-09-28 Option Award |
2021-09-30 5:45 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
6,667 | $0 | 177,535 (Direct) |
View |
| 2021-09-28 Tax Withholding |
2021-09-30 5:43 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
2,306 | $6.5 | 94,485 (Direct) |
View |
| 2021-09-28 Option Award |
2021-09-30 5:43 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
6,667 | $0 | 94,485 (Direct) |
View |
| 2021-03-22 Exercise |
2021-03-25 9:30 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director |
20,000 | $1.5 | 46,250 (Direct) |
View |
| 2021-03-22 Exercise |
2021-03-25 9:30 pm |
2016-04-13 2021-04-13 |
Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director |
20,000 | $0 | 46,250 (Direct) |
View |
| 2021-01-19 Tax Withholding |
2021-01-19 6:25 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
808 | $6.68 | 89,751 (Direct) |
View |
| 2021-01-19 Tax Withholding |
2021-01-19 6:23 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
994 | $6.68 | 169,952 (Direct) |
View |
| 2021-01-15 Tax Withholding |
2021-01-19 6:23 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
686 | $6.48 | 169,952 (Direct) |
View |
| 2021-01-19 Tax Withholding |
2021-01-19 6:21 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP, Finance and Administration |
1,685 | $6.68 | 116,062 (Direct) |
View |
| 2021-01-19 Tax Withholding |
2021-01-19 6:19 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
5,611 | $6.68 | 1,894,181 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:42 pm |
2022-01-04 2031-01-04 |
Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:41 pm |
2022-01-04 2031-01-04 |
Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:40 pm |
2022-01-04 2031-01-04 |
Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:39 pm |
2022-01-04 2031-01-04 |
Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:38 pm |
2022-01-04 2031-01-04 |
Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:37 pm |
2022-01-04 2031-01-04 |
Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP, Finance and Administration |
54,334 | $0 | 150,747 (Direct) |
View |
| 2021-01-04 Tax Withholding |
2021-01-06 4:37 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP, Finance and Administration |
2,739 | $5.8 | 150,747 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:34 pm |
2022-01-04 2031-01-04 |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
573,333 | $0 | 2,268,792 (Direct) |
View |
| 2021-01-03 Tax Withholding |
2021-01-06 4:34 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
31,545 | $5.63 | 2,268,792 (Direct) |
View |
| 2021-01-04 Tax Withholding |
2021-01-06 4:34 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
16,973 | $5.8 | 2,268,792 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:28 pm |
2022-01-04 2031-01-04 |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
149,450 | $0 | 168,559 (Direct) |
View |
| 2021-01-04 Tax Withholding |
2021-01-06 4:28 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
2,787 | $5.8 | 168,559 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:26 pm |
2022-01-04 2031-01-04 |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
169,750 | $0 | 261,632 (Direct) |
View |
| 2021-01-04 Tax Withholding |
2021-01-06 4:26 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
2,773 | $5.8 | 261,632 (Direct) |
View |
Ownership |
2021-01-06 4:22 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer |
0 | $0 | 191,146 (Direct) |
View |
Ownership |
2021-01-06 4:19 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer |
0 | $0 | 398,682 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-16 5:21 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP, Finance and Administration |
4,500 | $0 | 97,873 (Direct) |
View |
| 2020-09-15 Tax Withholding |
2020-09-16 5:21 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP, Finance and Administration |
1,557 | $6.25 | 97,873 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-16 5:18 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
55,500 | $0 | 1,742,363 (Direct) |
View |
| 2020-09-15 Tax Withholding |
2020-09-16 5:18 pm |
N/A N/A |
Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO |
19,192 | $6.25 | 1,742,363 (Direct) |
View |